Glenmark Pharma is likely to report 16 percent year-on-year growth in fourth quarter revenue at Rs 1,240 crore, whilenet profit is seen flat at Rs 150 crore, according to a CNBC-TV18 poll.
first published: May 7, 2013 01:47 pm
A collection of the most-viewed Moneycontrol videos.

Who says Debt Funds are boring?

Market Swings Between Gains & Losses Even As India-EU Finalise Landmark FTA | Closing Bell Live

Nifty At Over 3-Month Low; Will The Bulls Make A Comeback?| Opening Bell Live

Small town, Big tech: Sridhar Vembu on Zoho’s rural push, AI Bubble, SaaS consolidation & many more
You are already a Moneycontrol Pro user.

